Zantac, a medication often used to treat heartburn and acid reflux, has been linked to an increased risk of lung cancer. The Food and Drug Administration (FDA) is currently investigating the potential link between the two, and they urge all patients taking Zantac to consult their doctors.
Recently, the Food and Drug Administration (FDA) revealed that Zantac could cause cancer, and victims are now filing lawsuits against the drug manufacturer. Have you or a loved one been taking the heartburn medication Zantac and were subsequently diagnosed with lung cancer? You may be entitled to compensation.
The personal injury attorneys at Rosenfeld Injury Lawyers, LLC are legal advocates for injured parties harmed by the negligence of drug manufacturers selling defective merchandise and medications.
Contact our drug injury lawyers at (888) 424-5757 or use the contact form for additional information and answers, or schedule a free case evaluation to discuss your case. All confidential or sensitive information you share with our legal team remains private through an attorney-client relationship.
What is Zantac?
Zantac is a medication often used to treat heartburn and acid reflux. The medication was first sold in the United States in 1983 and quickly became one of the most popular drugs on the market. Zantac is available both over-the-counter and by prescription.
The active ingredient in Zantac is ranitidine hydrochloride, which belongs to a class of drugs known as histamine-2 (H2) blockers. The drug was effective in reducing stomach acid and was thought to be safe for long-term use.
However, recent studies have linked Zantac to an increased risk of lung cancer. The FDA is investigating the potential link between the two and urges all patients taking Zantac to consult their doctors.
A recent study conducted by the Mayo Clinic has found a link between Zantac and lung cancer. If you or someone you know is taking this medication, it’s essential to be aware of the risks associated with its use.
NDMA Found in Zantac Products: How Can Zantac Cause Lung Cancer?
NDMA (N-Nitrosodimethylamine) is a semi-volatile organic chemical used to produce synthetic rubber and plastics. The toxic chemical has also been used as a solvent and a stabilizer in some medications, including Zantac.
The National Cancer Institute (NCI) defines NDMA as “a chemical found in many foods, cosmetics, and other consumer products. It is also a by-product of tobacco smoke.” The Institute continues to say that “studies have shown that NDMA can cause [lung] cancer in laboratory animals.”
In recent years, NDMA has been linked to an increased risk of lung and liver cancer.
NDMA Exposure and Lung and Liver Cancer
According to the American Lung Association (ALA), “NDMA is classified as a ‘probable human carcinogen’ by the U.S. Environmental Protection Agency (EPA) and as a ‘known human carcinogen’ by the International Agency for Research on Cancer (IARC).”
The EPA has classified NDMA as a Group B2 probable human carcinogen, meaning it is “likely to be carcinogenic to humans.” The IARC has classified NDMA as a Group 2A human carcinogen, meaning it is “probably carcinogenic to humans.”
The ALA says that “NDMA has been shown to cause [lung] cancer in laboratory animals. Studies in rats and mice have found that NDMA exposure increases the risk of several types of cancer, including liver and lung cancer.”
While the link between NDMA and lung cancer is still being studied, the EPA has released a report that found that “NDMA is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.”
The FDA Has Linked Zantac to NDMA
In September 2019, the FDA announced that it had found “unacceptable levels” of NDMA in some Zantac (ranitidine) drugs. The agency has since issued a warning to all patients taking the medication, urging them to consult their doctor and seek alternative treatments.
The FDA is currently investigating the potential link between Zantac and NDMA. The agency has asked all manufacturers of ranitidine-containing products to test their products for the presence of NDMA.
In September 2019, the FDA recalled all Zantac (ranitidine) products. By April 2020, the agency ordered the immediate withdrawal of all Zantac products, including OTC (over-the-counter) including generic versions (ranitidine).
At that time, Zantac product manufacturers recalled their ranitidine medications stating that the products might be carcinogenic because of the chemical NDMA used in its production.
Even though the manufacturer or FDA recalls the products after discovering that ranitidine and Zantac cause cancers, injured parties can still seek compensation for harm caused by years of taking the acid reflux drug even if they switched to alternative medication.
Why Victims are Filing Zantac Cancer Lawsuits
Many victims who developed cancer have filed civil Zantac cancer lawsuits against the manufacturers, alleging that the drug maker and distributors knew of their products’ carcinogenic properties but never disclosed the known health risks.
The plaintiffs are also alleging that drug makers were slow at stopping the sale and availability of Zantac in America, even with all the public controversy revealing problems in 2019.
Diagnosed with Cancer?
Did you develop cancer and suspect the condition is the result of your long-term use of Zantac or other ranitidine products? Do you believe you developed cancer from exposure to NMDA in Zantac drugs that might include:
- Bladder cancer
- Stomach cancer
- Colorectal cancer
- Intestine cancer
- Liver cancer
- Prostate cancer
- Lung cancer
- Esophageal cancer
- Other cancers and respiratory tract health conditions
You might qualify to file a Zantac lung cancer lawsuit against the drug maker. Many people like you who are affected by N-Nitrosodimethylamine (NDMA) are holding the drug manufacturer accountable for their negligence that caused harm.
Hire a Ranitidine Cancer Law Firm to Resolve Your Personal Injury Claim
Filing and resolving a product liability case is challenging. Our legal team can help you show conclusive evidence of a link between your taking Zantac or other ranitidine product and exposure to NDMA that caused your cancer.
Our product liability lawyers build cases against those at fault to show how their negligent failure to disclose cancer risk information makes them accountable for hurting consumers.
Contact our personal injury team at (888) 424-5757 (toll-free phone call) or use the contact form today to schedule a free consultation.
We accept all product liability claims on contingency fee agreements that will postpone your need to pay us for our legal services until we resolve your Zantac cancer case through a negotiated settlement or jury award.
Can Zantac Cause Lung Cancer Resources:
- Ranitidine Drug & Cancer Fear-Drugwatch
- Zantac Recall – Harvard Health